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ABSTRACT
Objective: To explore the purpose/s for which people
with chronic conditions and their carers use Australian
community pharmacies, and compare this to what
pharmacy services they consider important, from the
perspectives of both consumers and pharmacists.
Design: An exploratory study involving a survey,
which asked participants to indicate the pharmacy
services they had ever used, and rate the importance of
22 pharmacy services to them, or the person they care
for, or for their consumers if a pharmacist.
Setting: Four regions of Australia: Logan-Beaudesert
and Mt Isa/North West region, Queensland, Northern
Rivers, New South Wales, and the Greater Perth area,
Western Australia.
Participants: Surveys were undertaken with 602
consumers and 91 community pharmacists.
Results: Community pharmacy is predominantly used
to obtain advice about medication and whether a doctor’s
visit is necessary, as well as for monitoring and
screening services. Pharmacy services that were patient
centric were important, such as individualised medication
advice and respectful care, as well as tools or procedures
to facilitate streamlined medication access. Less
important services included adult vaccinations and health
and wellness programmes. Carers identified services that
assisted them with their specific role/s to be important.
Overall, community pharmacists had a good
understanding of the services that were important to
people with chronic conditions and their carers.
Conclusions: People with chronic conditions and their
carers not only care about what services are delivered,
but how they are delivered; they sought services that
generally improved their access to medication and
information, but in a way that was patient centred.
Ultimately, pharmacists understood the importance of
patient-centred care for people with chronic conditions
and their carers, perhaps indicating a greater acceptance
of integrating patient-centred care into their everyday
practice.
INTRODUCTION
The scope of practice for pharmacists is
expanding, yet not all new roles or pharmacy
services beyond medication advice or supply
have been utilised to their full potential. For
example, Portuguese consumers did not
identify the need for, or the pharmacist’s
role in, therapeutic drug monitoring.1 This
may be for many reasons, including lack of
consumer awareness of these services, or the
pharmacist’s role.2–4 A recent Australian
project explored the needs of consumers
with respect to community pharmacy, and
highlighted the importance of increasing
public awareness of pharmacy services.5
Unfortunately, this is no different from a rec-
ommendation made by a similar project
10 years earlier.6
While there are reports of pharmacist
awareness weeks or campaigns,7–9 an evalu-
ation of their impact is limited, with
research mostly assessing the effectiveness
of speciﬁc health campaigns or pro-
grammes, which involve pharmacists.10–13
Furthermore, it has been proposed that
Strengths and limitations of this study
▪ This large, consumer-driven study has provided
in-depth information in an area that has received
limited attention, that is, what pharmacy service
or care is important to people with chronic con-
ditions and their carers.
▪ This study was informed by, and adds to, previ-
ous findings from a larger project.
▪ Most studies have generally explored pharma-
cists’ perceptions or preferences for extended or
future roles, or patient-centred services. Instead,
pharmacists were asked to reflect on what they
thought their clients’ priorities would be.
▪ A longitudinal approach would give an indication
if a person’s use of pharmacy changes over
time, particularly if the condition worsens.
▪ Researchers could not ascertain if the services
participants did not access were actually avail-
able in the pharmacy they used.
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simple awareness of available services is not enough to
facilitate change in pharmacy utilisation.4 Further
factors may need to be considered, such as increasing
consumer trust in the pharmacist’s ability to perform
new services or different roles.4 Schommer and
Gaither3 identiﬁed the importance of breaking the
‘care and respect’ cycle;3 if pharmacists show little
care for the consumer, then the result is a correspond-
ing level of respect for pharmacists’ skills, with the
cycle continuing. It has been proposed that pharmacy
services need to be designed in a way to improve
public trust, such as continual consultations with one
pharmacist.4 Given that a recent concept analysis of
treatment burden identiﬁed that poor-health profes-
sional–consumer relationships and a lack of treatment
information are associated with higher levels of treat-
ment burden,14 optimising relationships is important.
Care that is individualised, holistic, respectful and
empowering, that is, patient-centred care,15 can facilitate
the development of professional and patient relation-
ships.16 Indeed, this approach to healthcare has also
been shown to inﬂuence a consumer’s choice of phar-
macy17 and their perceptions of service quality.18 Yet
while patient-centred care involves providing services
that meet patient or consumer needs, or are delivered
in an appropriate way, or both, there has been minimal
research into the importance of pharmacy services that
are patient centred, from the perspective of consumers.
For example, researchers have explored consumer views
of patient-centred professionalism in the context of com-
munity pharmacy,19–21 but not with respect to actual ser-
vices. The majority of pharmacy studies have evaluated
consumer perceptions of speciﬁc services or the role of
pharmacists in community pharmacy,22–25 consumer pre-
ferences or priorities with respect to a speciﬁc service or
role,26 27 or how services could be improved for speciﬁc
populations.2 Despite recognising the importance of
identifying what consumers want or expect from com-
munity pharmacy,26 28 their views have only been
researched from limited perspectives.
There is also limited information as to what pharmacists
think consumers want with respect to patient-centred
pharmacy services. Most studies have generally explored
pharmacists’ perceptions29 30 or preferences31 32 for
extended or future roles, or patient-centred services.
Therefore, the results may not be aligned with what consu-
mers actually want. Recently, Assa-Eley and Kimberlin33
explored the congruence of pharmacist and patient per-
ceptions with respect to services that would beneﬁt
patients. As hypothesised, pharmacists considered services
to be more beneﬁcial than patients, for example, explain-
ing how to use their medicines and asking questions to
identify medication problems.33 However, this American
study only included pharmaceutical care services that
solely focused on the quality use of medicines.33
Consequently, further research is needed to explore
pharmacist and consumer views in relation to other
patient-centred pharmacy services.
In the Australian context, some professional pharmacy
services are funded by agreements made every 5 years
between the Government and a key professional organ-
isation, known as the Community Pharmacy Agreement.
It is expected that this research will inform healthcare
professionals and policymakers as to what pharmacy ser-
vices should be prioritised from a consumer perspective.
More importantly, it goes beyond how people use the
pharmacy, which most research has focused on, to
identifying what services are important to them. This
research is particularly important for people with chronic
conditions and their carers, who can experience high
levels of treatment burden14 and frequently access com-
munity pharmacies. Furthermore, with the Australian
Government planning to introduce a copayment for
Australian residents to see their general practitioner
(GP),34 it could be anticipated that more of these consu-
mers will seek help from their community pharmacy.
Overall, this study aims to recognise the purpose/s for
which Australian residents with chronic conditions and
their carers currently use community pharmacy, and
compare this to what pharmacy services they consider
important, from the perspective of both consumers and
pharmacists.
METHOD
This study was part of a larger project exploring consu-
mers’ perspectives on the burden of chronic conditions
and the role of community pharmacy to help manage
these conditions. This project incorporated semistruc-
tured interviews, groups using the nominal group tech-
nique and a self-reported survey. Data were selected
from the survey to address the study aims above. The
remaining data were collected for other purposes, for
example, an evaluation of the treatment burden and a
Discrete Choice Experiment, and are35 (or will be)
reported elsewhere.
Participants
A diverse, purposive sample of people with chronic con-
ditions, unpaid carers and health professionals, for
example, pharmacists, doctors and allied health profes-
sionals, were recruited from four Australian regions:
Logan-Beaudesert and Mt Isa/North West region,
Queensland, Northern Rivers, New South Wales, and the
Greater Perth area, Western Australia. For this study,
only the data from consumers, carers and pharmacists
were selected. Other health professional data were
excluded as they are not directly involved in the core
delivery of pharmacy services, and were therefore not
related to the aims of this study. Consumers and carers
were required to meet at least one of the eligibility cri-
teria (box 1). The purpose of the sample was to repre-
sent diversity in location, age, socioeconomic status,
culture and chronic condition/s. This ensured the
recruitment of people with varying health complexities
and experiences with community pharmacy, including
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those eligible for more in-depth services such as medica-
tion management services, for example, MedsCheck (a
form of medication review), which would provide a dif-
ferent pharmacy experience. Pharmacists were eligible
to participate in the study if they had recently or cur-
rently worked in a community pharmacy within one of
the four project areas, and therefore were expected to
have knowledge of current pharmacy practice.
Participant recruitment involved the targeted provision
of study information and enrolment in a variety of loca-
tions, for example, medical practices, healthcare clinics,
community pharmacies, shopping centres and formats,
for example, newspaper articles and advertisements.
Further information was provided to non-government
consumer health organisations, for example, Diabetes
Australia, and professional bodies, for example, The
Pharmaceutical Society of Australia.
Survey development
The survey was informed by previous project ﬁndings,
including semistructured interviews17 36 and nominal
groups.37 The survey was comprehensive as it addressed
several aims of the overall project. To address the aims
of this study, the survey asked consumers to indicate
which pharmacy services they had ever used, that is, by
ticking all the services that applied, as well as to rate the
importance of each service on a visual analogue scale of
0–100, that is, 100=the pharmacy service has a very high
importance for me and 0=this pharmacy service is not import-
ant to me. The visual analogue scale was selected after
discussion between research project members, as there
were no validated scales for this measurement, and we
wished to capture subtle variations in opinions which
are not possible with a more truncated scale, that is,
0–10. As previous stages of the project have identiﬁed
that pharmacies are commonly utilised for medication
access,36 38 survey questions focused beyond this service.
Identical questions were given to community pharma-
cists, except that they were asked to consider the services
that their consumers would like from pharmacy or phar-
macists to help them with their situation, not what they
would personally want as a pharmacist.
Feedback on the survey was obtained from iterative
rounds of pilot testing with consumers and health pro-
fessionals, the project Reference Group and Advisory
Panel (both of which consisted of a range of key health-
care stakeholders), and a plain English reviewer. Minor
changes were made to improve the readability of the
survey for people who may have limited literacy levels.
Study procedure
The survey was conducted between October 2013 and
January 2014. Study information and surveys were ﬁrst
posted or emailed to potential participants, who were
subsequently contacted to conﬁrm a date and time for a
telephone or face-to-face interview. The majority of parti-
cipants were guided through a telephone interview with a
consumer-assisted telephone interview provider, who
recorded the responses. However, some surveys were con-
ducted face to face by the researchers, particularly for
groups who preferred this approach or were considered
difﬁcult to reach via telephone. Both verbal and written
consent were obtained prior to data collection.
Data analysis
Survey results were analysed descriptively, with the
median and IQR identiﬁed for each pharmacy service.
SPSS V.22 was used for statistical analysis.
RESULTS
Overall, 849 consumers and carers expressed interest in
the survey with a total of 602 participants (70.9%
response). The majority of participants were female
(68.5%), had an annual household income of below
$A50 000 (60.5%), experienced two or more chronic
conditions (83.2%), and had a mean age of 57.0 years
(range 17–89 years). From the 601 participants who
identiﬁed their ethnic or cultural background, 61.3%
(n=368) were Australian, 9.0% (n=54) were Aboriginal
and Torres Strait Islander peoples, and 29.7% (n=179)
were culturally and linguistically diverse. Most partici-
pants were from the Logan-Beaudesert region (n=236;
39.2%), followed by Northern Rivers (n=191; 31.7%),
then Greater Perth (n=133; 22.1%) and the Mt Isa/
North West region (n=42; 7.0%). The most common
conditions reported included high blood pressure, arth-
ritis, chronic pain, depression, anxiety and asthma.
From the 412 healthcare professionals expressing
interest, 297 participated (72.1% response), including
91 pharmacists. The majority of pharmacists were female
(68.1%), Australian (57.1%), had practised for ﬁve or
more years (63.7%), and had a mean age of 37.5 years
Box 1 Eligibility criteria for study participants*
Have one or more long-term health condition(s) for at least
6 months.
Recently diagnosed with a long-term health condition (in the pre-
vious 6 months).
Recently started to use pharmacy services (eg, blood pressure
testing).
Take five or more regular medications.
Take more than 12 doses of medication each day.
Experienced difficulties/significant changes to medication routine
in the past 3 months.
High user of medical services (eg, visit a general practitioner at
least 12 times annually).
Qualified for cheaper prescription medication this year or last year
(medication payment subsidy paid by the Australian Government).
Aboriginal or Torres Strait Islander who qualifies for the ‘Closing
the Gap’ copayment (medication payment subsidy paid by the
Australian Government).
Care for someone with a chronic condition.
*Consumers had to either have a chronic condition or be an
unpaid carer. The other criteria were used to ensure participant
diversity.
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(range, 22–66 years). More participants worked in Perth
(36.2%), followed by Logan-Beaudesert (29.7%),
Northern Rivers (26.4%) and the Mt Isa/North West
region (7.7%). Small proportions of pharmacists cared
for someone with (16.5%), or had (9.9%), one or more
chronic condition/s, or both (4.4%).
Community pharmacy use
The pharmacy service accessed most frequently by con-
sumers and carers was the opportunity to discuss their
medication (n=397; 66.5%), followed by advice as to
whether a GP’s appointment was needed (n=195;
32.7%) and then health screening and monitoring
(n=152; 25.5%). Home deliveries and dose administra-
tion aids were less frequently utilised services; however,
carers were higher users of dose administration aids
than other consumer participants (table 1).
The importance of specific pharmacy services: consumer,
carer and pharmacist perspectives
The most important services for consumers and carers
in the survey were those with a median score of 90 or
above, and the least important services were those with a
median score below 50 (table 2). Overall, community
pharmacists had a good understanding of the services
that were important to people with chronic conditions
and their carers. For example, the two highest (most
important) and two lowest (least important) rated
characteristics of pharmacy services were identical for
both groups (table 2). The most important service
characteristics for consumers and carers (as a combined
total group), as veriﬁed by pharmacists, were related to
how services were provided, that is, individualised and
respectful care. High ratings were also associated with
actual services or service characteristics, such as those
relating to medication management (‘provide persona-
lised advice and information on prescribed medicines’)
and new services for Australia (‘prescribe a short course
of medication under a healthcare plan that has been
agreed with the GP, without needing to see a GP’). The
least important services or service characteristics were
the provision of community health and wellness pro-
grammes and adult vaccinations.
With respect to differences in opinion, pharmacists
overestimated the importance of advice on minor ail-
ments and the pharmacist’s availability for consultations,
that is, positioned outside of the dispensary, to consu-
mers and carers. Pharmacists also underestimated the
importance of improved access to medication, such as
prescription reminders and access to a consumer’s dis-
pensing history from all pharmacies.
There were also some differences between what
people with chronic conditions and their carers believed
were important pharmacy services. Services that assisted
carers with role/s, such as being a partner in the health-
care of the care-receiver, home deliveries, repeat pre-
scription reminders, monitoring and screening services,
and for the pharmacist to be available for consultations
in a variety of ways, including via email and telephone,
were viewed as important. Carers also placed greater
importance on a private consultation area to discuss
medication than participants with chronic conditions.
Alternatively, respecting personal needs and values was
more important for consumers.
Table 1 Pharmacy services used by consumers and carers (survey)
Consumers
(n=442) Carers (n=21) Both (n=139) Total* (n=602)
n Per cent n Per cent n Per cent n Per cent
Type of pharmacy services accessed†
Discussing medications at pharmacy‡ 280 63.8 15 75.0 102 73.9 397 66.5
Deciding to see a doctor 135 30.8 6 30.0 54 39.1 195 32.7
Health screening/monitoring 102 23.2 5 25.0 45 32.6 152 25.5
Home deliveries 81 18.5 5 25.0 37 26.8 123 20.6
Dose administration aids 60 13.7 6 30.0 34 24.6 100 16.8
Discussing medications at home§ 58 13.2 3 15.0 23 16.7 84 14.0
Weight management 36 8.2 1 5.0 13 9.4 50 8.4
Needle and syringe exchange 33 7.5 0 0 11 8.0 44 7.4
Quit programme 22 5.0 1 5.0 13 9.4 36 6.0
Glucometer testing 22 5.0 0 0 9 6.5 31 5.2
Vaccinations 20 4.6 0 0 8 5.8 28 4.7
None of these services 78 17.8 3 15.0 15 10.9 96 16.0
Other service¶ 37 8.4 0 0 17 12.3 54 9.0
*Type of services accessed at the pharmacy had missing/incomplete data. Percentages are based on the actual number of individual
responses.
†Total for the type of pharmacy services accessed exceeds 100% as respondents were asked to indicate all that applied.
‡Discussing medications at the pharmacy could be an ad hoc discussion or counselling session, or involve a more structured professional
service such as a MedsCheck.
§Known as a home medication review in Australia.
¶Included returning unused medications, naturopathy, bone density testing, etc.
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Table 2 The importance of specific community pharmacy services in helping to manage the chronic conditions of consumers and/or unpaid carers
Future community pharmacy service
Consumers
(n=442) Carers (n=21)
Consumers/
carers (both;
n=139) Total (n=602)
Pharmacists
(n=91)
Median IQR* Median IQR* Median IQR* Median IQR* Median IQR*
Treat me as an individual, not as a number 100.0 20.0 100.0 20.0 100.0 20.0 100.0 20.0 100.0 10.0
Be respectful of needs and personal values 100.0 25.0 80.0 25.0 95.0 20.0 98.5 25.0 100.0 7.5
Provide personalised advice and information on prescribed medicines 90.0 30.0 99.0 25.0 90.0 25.0 90.0 25.0 90.0 20.0
Have access to my prescription (dispensing) records from any pharmacy 90.0 45.0 100.0 20.0 90.0 40.0 90.0 40.0 80.0 30.0
Be a partner in healthcare (eg, work with me and my family) 80.0 50.0 100.0 20.0 80.0 40.0 80.0 50.0 80.0 30.0
Prescribe a short course of medication under a healthcare plan that has been
agreed with the GP, without needing to see the GP
80.0 50.0 90.0 45.0 75.0 50.0 80.0 50.0 80.0 20.0
Recognise and value all parts of my life 80.0 50.0 75.0 45.0 80.0 50.0 80.0 50.0 90.0 20.0
Have access to my medical records, with links to my GP, specialist/hospital 80.0 50.0 90.0 40.0 80.0 50.0 80.0 50.0 70.0 30.0
Offer advice on the management of minor ailments 75.0 40.0 75.0 40.0 75.0 45.0 75.0 40.0 90.0 20.0
Be available in the pharmacy but away from the dispensary for consultation 70.0 40.0 77.5 42.5 75.0 40.0 75.0 40.0 90.0 20.0
Be able to speak with and put me in touch with other health professionals/services 75.0 40.0 80.0 50.0 75.0 50.0 75.0 40.0 80.0 20.0
Prescribe an extra 6 months repeat medicines after the GP prescription runs out 75.0 60.0 85.0 60.0 75.0 70.0 75.0 60.0 70.0 30.0
Send reminders when my repeat prescription is due 75.0 54.0 85.0 50.0 75.0 50.0 75.0 50.0 50.0 20.0
Have a private consultation area for discussions about medicines and health 68.0 45.0 82.5 75.0 75.0 40.0 70.0 40.0 90.0 25.0
Review my medicines—either in the pharmacy or at home 70.0 60.0 80.0 75.0 75.0 40.0 70.0 50.0 80.0 20.0
Be available on the phone, internet or email for consultations 60.0 60.0 72.5 45.0 72.5 30.0 70.0 50.0 80.0 20.0
Offer screening and monitoring services 60.0 65.0 75.0 70.0 70.0 60.0 70.0 65.0 75.0 20.0
Offer home delivery for medicines 55.0 65.0 67.5 80.0 70.0 70.0 60.0 65.0 75.0 30.0
Be located in a large community clinic/medical centre as part of a one-stop shop 60.0 65.0 70.0 75.0 70.0 65.0 60.0 65.0 70.0 30.0
Have other health providers working at the pharmacy 60.0 50.0 70.0 30.0 65.0 65.0 60.0 50.0 60.0 25.0
Provide basic adult vaccinations or treatments 50.0 70.0 60.0 70.0 50.0 65.0 50.0 60.0 50.0 30.0
Offer community health and wellness programmes 50.0 60.0 40.0 60.0 50.0 70.0 50.0 65.0 40.0 25.0
The most important services according to consumer and carer participants have a median score of ≥90 (out of 100 points).
*IQR between the 25th and 75th centile.
GP, general practitioner.
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DISCUSSION
Overall, participants primarily utilise community phar-
macies for medication advice, which corroborates ﬁnd-
ings from the project’s semistructured interviews36 and a
recent Australian study.5 Indeed, all parties, consumers,
carers and pharmacists, recognised the importance of
pharmacists to provide individualised medication advice.
This outcome aligns with our study population who are
likely to be regular medication users, carers who assist
with medication management, or both. This is therefore
a service that pharmacies need to continue to deliver to
this population, with an emphasis also on how it is deliv-
ered, that is, in a personalised way. Ultimately, when
asked to rate the importance of speciﬁc pharmacy ser-
vices, how services were delivered rated higher than what
was delivered. Although there were differences in
importance ratings for some services between pharma-
cists and consumers and carers, in this respect, pharma-
cists were of the same opinion, demonstrating a good
understanding of what was important to these consu-
mers, that is, patient-centred care.
Strengths and limitations
By exploring what services are important to people with
chronic conditions and their carers, and how this differs
from their current use of pharmacy and the views of
pharmacists, this study provides valuable insights regard-
ing service development and delivery for these consu-
mers. There has been limited research in this area for
such a diverse group of people with chronic conditions,
or carers, and a further strength of this study was its
consumer-driven approach. Furthermore, this study was
informed by previous ﬁndings from the larger
project,17 36–38 which also strengthens the above results.
However, there are some limitations to this work. The
results may not be generalisable to countries with differ-
ent healthcare systems from Australia. The researchers
could not ascertain if the services participants did not
access were actually available in the pharmacy they used.
There was also the risk of investigator bias caused by utilis-
ing a mixture of face-to-face and telephone data collection
methods. However, this is also recognised as a strength in
terms of data triangulation, and ensured that groups that
might be considered difﬁcult to reach, including
Aboriginal and Torres Strait Islander peoples and cultur-
ally and linguistically diverse participants, had the oppor-
tunity to participate. Finally, while the survey included a
large and diverse sample of consumers, the number of
participants who were carers and not consumers was
smaller, potentially limiting the comparison between con-
sumer and carer perspectives expressed in the survey.
Considering that there is a greater emphasis on a
patient-centred approach to healthcare,39 it is reassuring
to see that Australian pharmacists understand the
importance of how services are delivered to people with
chronic conditions and their carers. However, while
studies have reviewed patient–pharmacist interactions
for patient-centred communication,40 and explored what
patient-centred professionalism means within the phar-
macy context,19–21 research exploring the application of
patient-centred care within a community pharmacy
setting is limited. It is clearly evident that pharmacists
and community pharmacy are missing from the litera-
ture on patient-centred interventions,41 and that further
research is needed in this area. Moreover, professional
pharmacy organisations should provide further assist-
ance to pharmacies to develop patient-centred services.
Assistance could include a support unit including online
resources and training for pharmacy staff, and assistance
for pharmacists to tailor services to individual clients.
Indeed, integration of patient-centred training of phar-
macy students into clinical training must be advocated.42
The service most commonly accessed by consumers
and carers was medication advice. However, this was not
the case for one-third of participants. This could be due
to a number of reasons, for example, these participants
may not need advice as they have been managing their
condition/s for a long period of time. Alternatively, con-
sumers may not seek information from community phar-
macists because of a lack of awareness of the pharmacist’s
role or expertise,36 or the current pharmacy environ-
ment. Similar factors are also believed to inﬂuence the
provision of patient-centred professionalism by the
pharmacist.21 It is often suggested that community phar-
macists consider their physical working environment,21
such as improving the lack of privacy,43 44 which can
impact on the public trust of pharmacists.4 However, in
this study, a private consultation room was of lower
importance for people with chronic conditions when
rating pharmacy service characteristics. Furthermore,
pharmacists overestimated the value of a private consult-
ation room. It may be that how pharmacy staff communi-
cate with consumers is more relevant than the actual
space when it comes to respecting privacy. The import-
ance of tailoring information by taking into account a
person’s context and experiences, as well as developing a
relationship to facilitate this information sharing, is in
accord with previous research.45 Our study corroborates
that information on prescribed medication is what
people with chronic conditions and their carers rate as
important from community pharmacies, even if they do
not currently utilise this service.
There are clear opportunities for community phar-
macy to become more involved in supporting consumers
to manage their chronic condition/s, and to further
assist carers. These include new roles for pharmacists,
such as prescribing a short course of medication under
a GP’s agreed healthcare plan, as well as implementing
tools to facilitate continuity and coordinated care, such
as a person’s medication dispensing history linked to all
community pharmacies. The importance of continued
medication supply was also conﬁrmed by two other
studies undertaken within the larger project,35 37 and
support for this role by Australian consumers has been
underscored by Hoti et al.46 This is even more relevant
given that their study recruited similar consumers to our
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study, that is, people who were regularly using prescrip-
tion medication.46
Medication management and supply services, such as
repeat prescription reminders, home deliveries, and the
opportunity to obtain a pharmacist’s advice in a way that
best suited them, for example, online or face to face,
was more important for carers than for people with
chronic conditions. Despite the smaller number of
carers in our sample (relative to consumers), these
results emphasise the importance of these speciﬁc ser-
vices to reduce carer burden. Yet the importance of pre-
scription reminders was underestimated by pharmacists
in the survey. Given that this service is relatively easy to
implement, for example, verbal or short message service
(SMS) text reminders for prescription renewal, this
should become, if it is not already, common practice in
Australian pharmacies. Australian pharmacists should
also consider the study ﬁndings before discontinuing,
reducing the availability, or increasing the costs of home
delivery services.47 At the very least, this service should
be offered to the carers that utilise their pharmacy.
People with chronic conditions and their carers placed
lower importance on pharmacists or pharmacies offering
health and wellness programmes, or providing basic adult
vaccinations. Pharmacists corroborated this ﬁnding. This
research did not explore the reasons behind why certain
services were more important than others, and so we can
only hypothesise. It is plausible that participants were
focusing on the daily management of their condition
rather than preventative measures when completing the
survey. People who have lived with a chronic condition for
a long time can become well informed about their condi-
tion/s, particularly with how it affects them,48 and many
would be eligible for inﬂuenza or pneumococcal vaccin-
ation, at no extra cost, during their GP consultation.
CONCLUSION
Overall, pharmacists had a reasonable understanding of
what consumers with chronic conditions and their carers
would rate as important in terms of pharmacy services.
Greater value was placed on how pharmacy services are
delivered, that is, in a patient-centred manner, particularly
when providing medication information. Ultimately, phar-
macists understood the importance of patient-centred
care for people with chronic conditions and their carers,
perhaps indicating a greater acceptance of integrating
patient-centred care into their everyday practice.
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